Phenylalanine hydroxylase deficiency
- PMID: 21555948
- DOI: 10.1097/GIM.0b013e3182141b48
Phenylalanine hydroxylase deficiency
Abstract
Phenylalanine hydroxylase deficiency is an autosomal recessive disorder that results in intolerance to the dietary intake of the essential amino acid phenylalanine. It occurs in approximately 1:15,000 individuals. Deficiency of this enzyme produces a spectrum of disorders including classic phenylketonuria, mild phenylketonuria, and mild hyperphenylalaninemia. Classic phenylketonuria is caused by a complete or near-complete deficiency of phenylalanine hydroxylase activity and without dietary restriction of phenylalanine most children will develop profound and irreversible intellectual disability. Mild phenylketonuria and mild hyperphenylalaninemia are associated with lower risk of impaired cognitive development in the absence of treatment. Phenylalanine hydroxylase deficiency can be diagnosed by newborn screening based on detection of the presence of hyperphenylalaninemia using the Guthrie microbial inhibition assay or other assays on a blood spot obtained from a heel prick. Since the introduction of newborn screening, the major neurologic consequences of hyperphenylalaninemia have been largely eradicated. Affected individuals can lead normal lives. However, recent data suggest that homeostasis is not fully restored with current therapy. Treated individuals have a higher incidence of neuropsychological problems. The mainstay of treatment for hyperphenylalaninemia involves a low-protein diet and use of a phenylalanine-free medical formula. This treatment must commence as soon as possible after birth and should continue for life. Regular monitoring of plasma phenylalanine and tyrosine concentrations is necessary. Targets of plasma phenylalanine of 120-360 μmol/L (2-6 mg/dL) in the first decade of life are essential for optimal outcome. Phenylalanine targets in adolescence and adulthood are less clear. A significant proportion of patients with phenylketonuria may benefit from adjuvant therapy with 6R-tetrahydrobiopterin stereoisomer. Special consideration must be given to adult women with hyperphenylalaninemia because of the teratogenic effects of phenylalanine. Women with phenylalanine hydroxylase deficiency considering pregnancy should follow special guidelines and assure adequate energy intake with the proper proportion of protein, fat, and carbohydrates to minimize risks to the developing fetus. Molecular genetic testing of the phenylalanine hydroxylase gene is available for genetic counseling purposes to determine carrier status of at-risk relatives and for prenatal testing.
Similar articles
-
Phenylalanine Hydroxylase Deficiency.2000 Jan 10 [updated 2017 Jan 5]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2000 Jan 10 [updated 2017 Jan 5]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301677 Free Books & Documents. Review.
-
Molecular analysis of the inheritance of phenylketonuria and mild hyperphenylalaninemia in families with both disorders.N Engl J Med. 1986 May 15;314(20):1276-80. doi: 10.1056/NEJM198605153142002. N Engl J Med. 1986. PMID: 3702929
-
5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.Mol Genet Metab. 2020 Mar;129(3):177-185. doi: 10.1016/j.ymgme.2019.12.007. Epub 2019 Dec 10. Mol Genet Metab. 2020. PMID: 31883647
-
Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in southern Europe.Hum Mol Genet. 1993 Oct;2(10):1703-7. doi: 10.1093/hmg/2.10.1703. Hum Mol Genet. 1993. PMID: 8268925
-
Mutations in the phenylalanine hydroxylase gene: genetic determinants for the phenotypic variability of hyperphenylalaninemia.Acta Paediatr Suppl. 1994 Dec;407:49-56. doi: 10.1111/j.1651-2227.1994.tb13451.x. Acta Paediatr Suppl. 1994. PMID: 7766959 Review.
Cited by
-
Predictive value of fluorometric method and tandem mass spectrometry for hyperphenylalaninemia and its subtypes in China: A systematic review and meta‑analysis.Exp Ther Med. 2024 May 10;28(1):278. doi: 10.3892/etm.2024.12566. eCollection 2024 Jul. Exp Ther Med. 2024. PMID: 38800050 Free PMC article.
-
Comparison of Cost Analysis in Patients with Tetrahydrobiopterin-Responsive and Non-Responsive Phenylketonuria in Turkey.Nutrients. 2024 May 10;16(10):1444. doi: 10.3390/nu16101444. Nutrients. 2024. PMID: 38794682 Free PMC article.
-
Intake Modalities of Amino Acid Supplements: A Real-World Data Collection from Phenylketonuria Patients.Nutrients. 2024 Feb 27;16(5):669. doi: 10.3390/nu16050669. Nutrients. 2024. PMID: 38474797 Free PMC article.
-
[In vitro expression and functional analyses of the mutants p.R243Q, p.R241C and p.Y356X of the human phenylalanine hydroxylase].Zhongguo Dang Dai Er Ke Za Zhi. 2024 Feb 15;26(2):188-193. doi: 10.7499/j.issn.1008-8830.2309035. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 38436318 Free PMC article. Chinese.
-
Management of patients with phenylketonuria (PKU) under enzyme replacement therapy: An Italian model (expert opinion).Mol Genet Metab Rep. 2024 Feb 22;39:101065. doi: 10.1016/j.ymgmr.2024.101065. eCollection 2024 Jun. Mol Genet Metab Rep. 2024. PMID: 38425869 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources